eyevensys.com
Home - EyevensysDeveloping breakthrough platforms for long acting non-viral gene therapy for ocular diseases
http://www.eyevensys.com/
Developing breakthrough platforms for long acting non-viral gene therapy for ocular diseases
http://www.eyevensys.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
1.6 seconds
16x16
32x32
64x64
128x128
160x160
192x192
Nicolas GIANNOLI
67 rue ●●●●●●●Jacques
Pa●●is , FR, 75005
France
View this contact
Nicolas GIANNOLI
67 rue ●●●●●●●Jacques
Pa●●is , FR, 75005
France
View this contact
Nicolas GIANNOLI
67 rue ●●●●●●●Jacques
Pa●●is , FR, 75005
France
View this contact
BUY YOUR DOMAIN
12
YEARS
3
MONTHS
4
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
18
SSL
EXTERNAL LINKS
8
SITE IP
82.165.151.158
LOAD TIME
1.612 sec
SCORE
6.2
Home - Eyevensys | eyevensys.com Reviews
https://eyevensys.com
Developing breakthrough platforms for long acting non-viral gene therapy for ocular diseases
eyevensys.com
Eyevensys
http://www.eyevensys.com/onepresse.php?id=8
The Eyevensys Breakthrough Technology. Eyevensys S.A.S. Presents at BioTrinity 2014 - European Biopartnering and Investment Conference. Eyevensys S.A.S. Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-12-2014 . Venue: London, United Kingdom. Eyevensys S.A.S announced the appointment of Mr. Raffy Kazandjian as CEO. Eyevensys S.A.S. announced the appointment of Mr. Raffy Kazandjian as CEO. Raffy Kazand. Eyevensys S.A.S. Presents at BioEquity Europe 2014.
Eyevensys
http://www.eyevensys.com/pages/19-overview-vision.html
The Eyevensys Breakthrough Technology. The Company’s mission is to address critical unmet needs in ophthalmology by overcoming the shortcomings of current therapeutic options in this area. The objective is not only to improve short and long term therapeutic outcomes, but also enhance compliance and improve tolerability. This achieve this goal, Eyevensys has developed a novel therapeutic approach based on the electro-transfection into the ciliary muscle of plasmids encoding therapeutic proteins.
Eyevensys
http://www.eyevensys.com/pages/10-medical-devices.html
The Eyevensys Breakthrough Technology. The Eyevensys Breakthrough Technology. In order to achieve a well-controlled protein delivery and expression in the eye, with high level of reproducibility and sustainability, Eyevensys developed a 2-prong approach. Firstly, in collaboration with Nature Technology Inc., Eyevensys developed a high expression plasmid devoid of any antibiotic selection genes. This results in a highly reproducible, dose-dependent, long-lasting protein expression in the eye.
Eyevensys
http://www.eyevensys.com/pages/12-clinical-trials.html
The Eyevensys Breakthrough Technology. The Eyevensys Breakthrough Technology. Eyevensys lead program targets the treatment of Non-Infectious Posterior Uveitis (NIU) that have become refractory to standard cortico-steroids. The Company is developing a soluble TNFalpha receptor to tackle the disease code-named EYS606. Eyevensys expects to complete regulatory pre-clinical studies of EYS606 by end 2015 and start a multi-centre European clinical trial in NIU early 2016. Eyevensys aims at improving treatment e...
Eyevensys
http://www.eyevensys.com/pages/20-the-evensys-team.html
The Eyevensys Breakthrough Technology. The Eyevensys has a small but fully dedicated team of 7 people, who manage and coordinate a network of external professional designers, product development specialists, CROs, regulatory advisors, and industrial partners. Mr Raffy Kazandjian, President and CEO. Dr Francine Behar-Cohen, Founder and Chief Scientific Officer of Eyevensys, MD, PhD. Violaine Desort-Henin, DVM, Chief Clinical Director. Bernard Scorneaux, PhD, Preclinical Director.
TOTAL PAGES IN THIS WEBSITE
18
Paris biotech Santé
http://www.parisbiotechsante.com/pbs7/projet&slc=pepiniere
Développer votre Projet en santé Humaine. Votre entrée en incubation. Entreprises de la pépinière. Porteur de projet : Gérard ULRICH. E-mail : gulrich@aterovax.com. Site Web : http:/ www.aterovax.com. Porteur de projet :. E-mail : contact@corwave.com. Site Web : http:/ www.corwave.com. Ses produits sont :. Porteur de projet : Ivan COHEN-TANUGI. E-mail : ivan.cohen-tanugi@eyevensys.com. Site Web : www.eyevensys.com. Porteur de projet : Frédéric MARIN. E-mail : fred@gmp-o.com. E-mail : contact@lltech.fr.
Paris biotech Santé
http://www.parisbiotech.org/pbs7/projet&slc=pepiniere
Développer votre Projet en santé Humaine. Votre entrée en incubation. Entreprises de la pépinière. Porteur de projet : Gérard ULRICH. E-mail : gulrich@aterovax.com. Site Web : http:/ www.aterovax.com. Porteur de projet :. E-mail : contact@corwave.com. Site Web : http:/ www.corwave.com. Ses produits sont :. Porteur de projet : Ivan COHEN-TANUGI. E-mail : ivan.cohen-tanugi@eyevensys.com. Site Web : www.eyevensys.com. Porteur de projet : Frédéric MARIN. E-mail : fred@gmp-o.com. E-mail : contact@lltech.fr.
Paris biotech Santé
http://www.parisbiotechsante.org/pbs7/projet&slc=pepiniere
Développer votre Projet en santé Humaine. Votre entrée en incubation. Entreprises de la pépinière. Porteur de projet : Gérard ULRICH. E-mail : gulrich@aterovax.com. Site Web : http:/ www.aterovax.com. Porteur de projet :. E-mail : contact@corwave.com. Site Web : http:/ www.corwave.com. Ses produits sont :. Porteur de projet : Ivan COHEN-TANUGI. E-mail : ivan.cohen-tanugi@eyevensys.com. Site Web : www.eyevensys.com. Porteur de projet : Frédéric MARIN. E-mail : fred@gmp-o.com. E-mail : contact@lltech.fr.
Spin-offs - Inserm Transfert
http://inserm-transfert.fr/en/achievements/spinoffs.html
Maturation, Protecting and IP. Partnering: R&D, Public health. Some remarkable spin-offs backed by Inserm's technology. More than 120 start-ups companies have been created over the past 35 years. Cancer and inflammatory diseases. Biomarkers for inflammatory chronic diseases. Cancer and chronic infectious diseases. All therapy for chronic inflammatory diseases. Maturation, Protecting and IP. Partnering: R&D, Public health. Paris Biopark - 7 rue Watt - 75013 PARIS. 33 (0)1 55 03 01 00. 33 (0)1 55 03 01 60.
Paris biotech Santé
http://www.parisbiotech.com/pbs7/projet&slc=pepiniere
Développer votre Projet en santé Humaine. Votre entrée en incubation. Entreprises de la pépinière. Porteur de projet : Gérard ULRICH. E-mail : gulrich@aterovax.com. Site Web : http:/ www.aterovax.com. Porteur de projet :. E-mail : contact@corwave.com. Site Web : http:/ www.corwave.com. Ses produits sont :. Porteur de projet : Ivan COHEN-TANUGI. E-mail : ivan.cohen-tanugi@eyevensys.com. Site Web : www.eyevensys.com. Porteur de projet : Frédéric MARIN. E-mail : fred@gmp-o.com. E-mail : contact@lltech.fr.
Clients & Partenaires: Nexialist
http://www.nexialist.fr/fr/clients-partenaires
Navigation par fil d'Ariane. Quelques-un de nos clients. Orthopédie, dispositifs implantables. Biocides - surfaces antimicrobiennes. Produits implantables et micro-systèmes mécaniques de haute précision. Pôle de compétitivité Santé - Pharma de PACA / LR. Groupe de travail d'Eurobiomed qui réunit les acteurs du diagnostic médical. Le pôle de compétitivité santé de Wallonie - Belgique. Institut Régional pour la Création et le développement des Entreprises. D Valicon, Directeur Général @ Julie Software.
boehringer-ingelheim-venture.com
Portfolio
http://www.boehringer-ingelheim-venture.com/portfolio.html
Boehringer Ingelheim Venture Fund 07 July 2016. Jump to main navigation. The Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies that have the potential to advance patient care and meet unmet medical needs. Year of investment: 2011; BIVF Board Representative: Martin Heidecker. Year of investment: 2011; BIVF Board Representative: Frank Kalkbrenner. Promethera Biosciences S.A./N.V. Year of investment: 2012; BIVF Board Representative: Ilka Wicke.
TOTAL LINKS TO THIS WEBSITE
8
Protected Blog › Log in
This site is marked private by its owner. If you would like to view it, you’ll need two things:. A WordPress.com account. Don’t have an account? All you need is an email address and password register here! Permission from the site owner. Once you've created an account, log in and revisit this screen to request an invite. If you already have both of these, great! Larr; Back to WordPress.com.
Barnicles!
Nippopolis Cockopolis Bar and Club.(I work there.). Friday, May 15, 2009. I wont swear anyways. But. They blocked Blogger, LUCKILY Simran found this internet. http:/ www.sneakme.com and then you go search! Yeah, basically i am not going to use blogger often already, since it is blocked. So.ByeT T. Labels: There goes blogger. Today is the love pluslplushplushh! I couldnt sleep last night, so excitedd! SECOND, I was waiting, i know it is going to be interesting! I made up the steps! So how much you love us?
eyeveins.com
Eyevel.com - Hire Remote Eyes
We believe that the world is a beautiful place, filled with constantly exploding interesting events, places to see and incredible business opportunities to seize; it's a pity that we can't experience them all just because we are limited by our physical location. Eyevel is a platform to allow you to live the immersive experience of unreachable places and events of the world through the eyes and devices, smartphone or Google Glass, of an expert guide. Imagine the endless possibilities!
eyeven (eyeven) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 6 Years. This deviant's full pageview. Last Visit: 34 minutes ago. This is the place where you can personalize your profile! Window...
Home - Eyevensys
We create ophthalmic therapeutic bio factories to sustainably treat major eye diseases. Eyevensys is a private biotechnology company developing a novel approach in the treatment of major ophthalmic diseases. We create a bio therapeutics factory in the eye to allow safe local sustained production of therapeutic proteins, an approach that can address a wide range of ophthalmic diseases. Dec 12, 2017. Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer. Sep 13, 2017. The EyeCET treatment proc...
EY Eventfully Yours Puttin on the Ritz wedding party decor rentals
No Content
We are not currently hosting any content in this area. Please use your 'back' button, to go to your previous page, or enter a different URL in the address box of your browser.
No Content
We are not currently hosting any content in this area. Please use your 'back' button, to go to your previous page, or enter a different URL in the address box of your browser.
EY Events - Home - Austin, TX
Eventfully Yours has changed its name to EY Events . EY Events is a full service event coordinating company located in Austin, Texas. We are there to ensure each event is spectacular a. Nd unique, from the first impression down to the smallest detail. Clients are guided through the planning process with expert advice, imaginative vision and a warm smile at every turn, making the event planning as enjoyable and memorable as the event itself.
